ClinicalTrials.Veeva

Menu

Bone Resistant Tuberculosis (TboneR)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Bone and Osteoarticular Infection Due to MDR M. Tuberculosis Strains

Treatments

Other: Descriptive retrospective study

Study type

Observational

Funder types

Other

Identifiers

NCT04928378
APHP210051

Details and patient eligibility

About

The recommendations for the treatment of MDR tuberculosis are based on pulmonary tuberculosis since there is a lack of specific recommendations for TB bone and osteoarticular disease, including those due to multi drug resistance strains (MDR IOATB). Given the lack of data regarding MDR IOATB, it may be helpful to study the diagnosis, medical treatment, surgical indications and prognosis of a cohort of MDR IOATB patients.

Full description

Due to the lack, in the guidelines regarding bone and osteoarticular infections due to MDR M. tuberculosis strains, this study aims to characterize the diagnosis, management and outcome of patients with osteoarticular infection due to MDR M. tuberculosis in France (MDR IOATB).

Aim: descriptive study of diagnosis, therapeutics and outcome of patients with bone and osteoarticular infection with MDR IOATB in France.

Set up: patients registered in the database of the National Reference Center (CNR) for MDR IOATB in France, treated for MDR IOATB between January 1, 2007 and December 31, 2018 will be included and analyzed.

Study design: retrospective study on historical cohort

Enrollment

23 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any patient with an MDR IOATB whose sample and / or strain has been referred to the National Reference Center (CNR) for mycobacteria in France, will be included.

Exclusion criteria

  • Patient refusing to have their data used.
  • Patients under guardianship or curators, patients under legal protection will not be included.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems